Has Rosa Zissimos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,190 in general payments to Rosa Zissimos, MD across 151 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rosa Zissimos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rosa Zissimos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rosa Zissimos, MD

Pain Medicine · Kissimmee, FLNPI 1609304054

Payments from drug & device makers

$14,190in general payments, 2019–2025

Across 151 payments — averaging $93.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$7K
Boston Scientific$4K
Relievant Medsystems, Inc.$711
Vertos Medical, Inc.$658
Nevro Corp.$551
AbbVie$526
plus $1K from 14 others

$1,065in research payments, 2019–2025

Across 3 payments — averaging $354.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boehringer Ingelheim International GmbH$1K

What the payments were for

Grants$3,00021%
Travel & lodging$3,68126%
Food & beverage$7,47153%
Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	42	$6,964
Boston Scientific	35	$3,519
Relievant Medsystems, Inc.	7	$711
Vertos Medical, Inc.	7	$658
Nevro Corp.	10	$551
AbbVie	18	$526
Curonix LLC	10	$405
Stryker	2	$295
MML US, Inc.	1	$109
Globus Medical	4	$89
Vertex	3	$81
Osteocentric Technologies, Inc.	1	$70
Averitas Pharma Inc.	2	$49
Abbott	2	$49
Convatec Inc.	1	$21
Bioventus LLC	1	$21
Leica Microsystems Inc.	1	$20
Stimwave Technologies Incorporated	1	$19
Tonix Medicines, Inc.	1	$18
SPR Therapeutics, Inc	2	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SYNCHROMED$3,000
VERTIFLEX SUPERION$1,272
Intracept$973
INTELLIS ADAPTIVESTIM$953
VANTA ADAPTIVESTIM$939
KYPHON EXPRESS II KYPHOPAK TRAY$913
Superion Indirect Decompression System$618
mild Device Kit$596
WaveWriter Alpha Prime 16$277
Omnia$245
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$245
GENERAL PAIN MANAGEMENT$211
WAVEWRITER ALPHA$161
Accurian$142
SPECTRA WAVEWRITER$142
OMNICURVE$131
OPTABLATE$131
ReActiv8$109
Senza$102

How this compares

$14,190 in reported general payments places this provider in the 85th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$71,658

Medicare patients

114

Services billed

2,266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Piroxicam	93	$50,347
Calcipotriene	96	$31,390
Diclofenac Sodium	142	$12,700
Gabapentin	421	$3,971
Pregabalin	124	$2,098
Duloxetine Hcl	79	$1,338
Celecoxib	26	$1,337
Methocarbamol	104	$1,112
Lidocaine	13	$903
Baclofen	91	$866
Cyclobenzaprine Hcl	92	$723
Ibuprofen	49	$337
Tizanidine Hcl	26	$331
Meloxicam	77	$243
Methylprednisolone	16	$115

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kissimmee

Anand PatelOrmond Beach$20.4M
Julio PaezClermont$2.3M
Joseph PergolizziNaples$2.1M
Abel MurilloMiami$1.6M
George MonluxPalm Coast$1.3M
Ferdinand FormosoJacksonville$1M
Cesar LassalleOrlando$1M
Robert GuirguisTampa$895K
Ashraf HannaClearwater$608K
Peter MichaelCoral Gables$496K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →